Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells.
作者信息
Badur Mehmet G, Muthusamy Thangaselvam, Parker Seth J, Ma Shenghong, McBrayer Samuel K, Cordes Thekla, Magana Jose H, Guan Kun-Liang, Metallo Christian M
出版信息
Cell Rep. 2018 Nov 6;25(6):1680. doi: 10.1016/j.celrep.2018.10.099.
Abstract
摘要
相似文献
1
Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells.致癌性R132 IDH1突变通过在纤维肉瘤细胞中产生（D）-2-羟基戊二酸限制用于从头脂肪生成的NADPH。
Cell Rep. 2018 Nov 6;25(6):1680. doi: 10.1016/j.celrep.2018.10.099.
2
Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Sells.致癌性 R132 IDH1 突变通过（D）2-羟戊二酸产生限制纤维肉瘤中的 NADPH 用于从头脂肪生成。
Cell Rep. 2018 Oct 23;25(4):1018-1026.e4. doi: 10.1016/j.celrep.2018.09.074.
3
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors.位于第132位残基的异柠檬酸脱氢酶1（IDH1）突变（IDH1(R132)）在高级别胶质瘤中频繁出现，但在其他实体瘤中则不然。
Hum Mutat. 2009 Jan;30(1):7-11. doi: 10.1002/humu.20937.
4
Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.在一例高级别星形细胞瘤中鉴定出异柠檬酸脱氢酶1（IDH1-R314C）的一种新型失活突变。
Sci Rep. 2016 Jul 27;6:30486. doi: 10.1038/srep30486.
5
Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1.固醇调节元件结合蛋白调控野生型和致癌性异柠檬酸脱氢酶1的表达及代谢功能。
Mol Cell Biol. 2016 Aug 26;36(18):2384-95. doi: 10.1128/MCB.00163-16. Print 2016 Sep 15.
6
Novel Insights for Inhibiting Mutant Heterodimer IDH1 in Cancer: An In-Silico Approach.新型抑制癌症中突变异二聚体 IDH1 的方法：一种计算机模拟方法。
Mol Diagn Ther. 2018 Jun;22(3):369-380. doi: 10.1007/s40291-018-0331-2.
7
NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival.NADP+ 依赖性 IDH1 R132 突变及其与胶质瘤患者生存的相关性。
Med Hypotheses. 2013 Jun;80(6):728-31. doi: 10.1016/j.mehy.2013.02.022. Epub 2013 Mar 29.
8
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.IDH1 R132 突变和 IDH1 单核苷酸多态性在核型正常的急性髓系白血病中的影响：SNP rs11554137 是一个不良预后因素。
J Clin Oncol. 2010 May 10;28(14):2356-64. doi: 10.1200/JCO.2009.27.6899. Epub 2010 Apr 5.
9
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells.雷帕霉素（mTORC1抑制剂）可降低异柠檬酸脱氢酶1（IDH1）突变的纤维肉瘤细胞中乳酸和2-羟基戊二酸等致癌代谢物的生成。
J Exp Clin Cancer Res. 2017 Jun 2;36(1):74. doi: 10.1186/s13046-017-0544-y.
10
Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.采用高分辨率熔解曲线分析快速可靠地检测急性髓系白血病中的 IDH1 R132 突变。
Clin Biochem. 2011 Jul;44(10-11):779-83. doi: 10.1016/j.clinbiochem.2011.04.014. Epub 2011 Apr 22.
引用本文的文献
1
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.初治异柠檬酸脱氢酶（IDH）突变型胶质瘤围手术期IDH抑制治疗：一项试点试验
Nat Med. 2025 Aug 21. doi: 10.1038/s41591-025-03884-4.
2
Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology.二硫化物依赖性细胞程序性坏死的分子特征：与程序性细胞死亡途径的相互作用及其在肿瘤学中的治疗意义
Cell Mol Biol Lett. 2025 Jun 2;30(1):66. doi: 10.1186/s11658-025-00743-5.
3
Valproic acid targets IDH1 mutants through alteration of lipid metabolism.丙戊酸通过改变脂质代谢靶向异柠檬酸脱氢酶1（IDH1）突变体。
NPJ Metab Health Dis. 2024;2(1):20. doi: 10.1038/s44324-024-00021-6. Epub 2024 Aug 13.
4
Mutant IDH in Gliomas: Role in Cancer and Treatment Options.胶质瘤中的突变异柠檬酸脱氢酶：在癌症中的作用及治疗选择
Cancers (Basel). 2023 May 23;15(11):2883. doi: 10.3390/cancers15112883.
5
Cytosolic and mitochondrial NADPH fluxes are independently regulated.细胞质和线粒体 NADPH 通量是独立调节的。
Nat Chem Biol. 2023 Jul;19(7):837-845. doi: 10.1038/s41589-023-01283-9. Epub 2023 Mar 27.
6
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.致癌性 IDH1 突变导致的脂质合成失调是一种可靶向的合成致死脆弱性。
Cancer Discov. 2023 Feb 6;13(2):496-515. doi: 10.1158/2159-8290.CD-21-0218.
7
Advances in measuring cancer cell metabolism with subcellular resolution.亚细胞分辨率下测量癌细胞代谢的进展。
Nat Methods. 2022 Sep;19(9):1048-1063. doi: 10.1038/s41592-022-01572-6. Epub 2022 Aug 25.
8
Helminthic dehydrogenase drives PGE and IL-10 production in monocytes to potentiate Treg induction.寄生虫脱氢酶驱动单核细胞中前列腺素 E 和白细胞介素 10 的产生，从而增强 Treg 的诱导。
EMBO Rep. 2022 May 4;23(5):e54096. doi: 10.15252/embr.202154096. Epub 2022 Mar 31.
9
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations.表达异柠檬酸脱氢酶突变的癌症中的代谢适应。
Cell Rep Med. 2021 Dec 21;2(12):100469. doi: 10.1016/j.xcrm.2021.100469.
10
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.烟酰胺腺嘌呤二核苷酸磷酸（NADPH）亏空导致氧化还原失衡：溶质载体家族7成员11（SLC7A11）/胱氨酸-谷氨酸反向转运体（xCT）介导的胱氨酸摄取在细胞氧化还原调节中是一把双刃剑。
Genes Dis. 2020 Nov 25;8(6):731-745. doi: 10.1016/j.gendis.2020.11.010. eCollection 2021 Nov.
Zotero 插件